Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study

References

• Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137–148.
   PubMed Web of Science ®Google Scholar
• Verma R, Foster RE, Horgan K, et al. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer. Breast Cancer Res. 2016;18(1):10.
   PubMed Web of Science ®Google Scholar
• Ewertz M, Christensen K, Engholm G, Academy of Geriatric Cancer Research (AgeCare), et al. Trends in cancer in the elderly population in Denmark, 1980-2012. Acta Oncol. 2016;55(Suppl 1):1–6.
   PubMed Web of Science ®Google Scholar
• WHO. Novel Coronavirus - China, in disease outbreak news. Geneva, Switzerland: World Health Organization; 2020. Available from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
   Google Scholar
• Zhu N, Zhang D, Wang W, China Novel Coronavirus Investigating and Research Team, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• Song F, Shi N, Shan F, et al. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020;295(1):210–217.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, the Northwell COVID-19 Research Consortium, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059.
   PubMed Web of Science ®Google Scholar
• Garassino MC, Whisenant JG, Huang LC, TERAVOLT investigators, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21(7):914–922.
   PubMed Web of Science ®Google Scholar
• Mcpadden J, Warner F, Young HP, et al. Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 infection. Version 4. medRxiv. Preprint 2020. DOI:https://doi.org/10.1101/2020.07.19.20157305
   Google Scholar
• Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–791.
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Choueiri TK, Shah DP, COVID-19 and Cancer Consortium, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918.
   PubMed Web of Science ®Google Scholar
• Pinato DJ, Zambelli A, Aguilar-Company J, et al. Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. Cancer Discov. 2020;10(10):1465–1474.
   PubMed Web of Science ®Google Scholar
• Lee LY, Cazier JB, Angelis V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549.
   PubMed Web of Science ®Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.
   Google Scholar
• Organization WH. International Classification of Diseases (ICD) Information Sheet. 2018. [cited 2018; 11th revision:[Available from: https://www.who.int/classifications/icd/factsheet/en/.
   Google Scholar
• Wu Z, Mcgoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Minor BL, REDCap Consortium, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, STROBE Initiative, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–808.
   PubMed Web of Science ®Google Scholar
• Saini KS, Tagliamento M, Lambertini M, et al. Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies. Eur J Cancer. 2020;139:43–50.
   PubMed Web of Science ®Google Scholar
• Ballout F, Daouk R, Azar J, et al. Cancerona: challenges of cancer management in times of COVID-19 pandemic. SN Compr Clin Med. 2020.DOI:https://doi.org/10.1007/s42399-020-00549-w
   Google Scholar
• Reilev M, Kristensen KB, Pottegard A, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49(5):1468–1481.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894–901.
   PubMed Web of Science ®Google Scholar
• Network EHR. Delayed Cancer Screenings. 2020. Available from: https://ehrn.org/delays-in-preventive-cancer-screenings-during-covid-19-pandemic.
   Google Scholar
• Curigliano G, Banerjee S, Cervantes A, Panel members, et al. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol. 2020;31(10):1320–1335.
   PubMed Web of Science ®Google Scholar